| From : | Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G> |
| To : | info <info@moh.gov.ge> |
| Subject : | FW: Favipiravir Meditop 200 mg (Hungarian product) |
| Cc : | Ekaterine Adamia <eadamia@moh.gov.ge> |
| Received On : | 19.03.2021 17:09 |
| Attachments : |
გთხოვთ დაარეგისტრიროთ
From: Varga Szabolcs dr. - TBS [mailto:szvarga@mfa.gov.hu]
Sent: 18 March, 2021 15:57
To: Tamar Gabunia
Subject: Favipiravir Meditop 200 mg (Hungarian product)
Dear Madame Deputy Minister,
Let me draw your attention that Hungarian company MEDITOP Ltd. has recently started to produce Favipiravir Meditop 200 mg tablets in higher quantities, with the financial support of the Hungarian government to extend the company’s production capacities.
Please do not hesitate to contact me directly in case Georgian medical institutions wish to purchase these products to use them in COVID-19 patients’ treatment. A detailed product description is attached hereby.
Kind regards,
Dr Szabolcs VARGA
Economic and Trade Counsellor
Embassy of Hungary
83 Lvovi Street
Tbilisi, Georgia